Algorithm Pipeline

Innovative diagnostic tools for detecting rare and hidden disease, based on the world’s largest labeled patient dataset, built to be integrated into existing physician workflows and currently pursuing FDA approval.

Program

Development

Pre-Submission

Validation

Submission

Approval

Low Ejection Fraction

Breakthrough designation*

Pulmonary Hypertension

Breakthrough designation*

Hypertrophic Cardiomyopathy

Amyloidosis

Atrial Fibrillation in Normal Sinus Rhythm

Aortic Stenosis

Myocarditis

Early Stage Development Programs

Low Ejection Fraction

Breakthrough designation*

Phase: Validation

Pulmonary Hypertension

Breakthrough designation*

Phase: Development

Hypertrophic Cardiomyopathy

Phase: Development

Amyloidosis

Phase: Development

Atrial Fibrillation in Normal Sinus Rhythm

Phase: Development

Aortic Stenosis

Phase: Development

Myocarditis

Phase: Development

Early Stage Development Programs

Phase: Development

*Granted FDA Breakthrough Designation

Partner with us!

We’re actively developing algorithms for FDA approval. Please direct partnership and media inquiries to info@anumana.net

Let's Connect

@2022 Anumana, Inc. All rights reserved.